Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The Board of Directors' decisions held on 29/04/2020.
The Decisions (298 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The Board of Directors' decisions held on 29/04/2020.
The Decisions (298 KB)
Comments